Cargando…
Risk Stratification of Early‐Stage Cervical Cancer with Intermediate‐Risk Factors: Model Development and Validation Based on Machine Learning Algorithm
BACKGROUND: Adjuvant therapy for patients with cervical cancer (CC) with intermediate‐risk factors remains controversial. The objectives of the present study are to assess the prognoses of patients with early‐stage CC with pathological intermediate‐risk factors and to provide a reference for adjuvan...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649058/ https://www.ncbi.nlm.nih.gov/pubmed/34427018 http://dx.doi.org/10.1002/onco.13956 |
_version_ | 1784610916633935872 |
---|---|
author | Chu, Ran Zhang, Yue Qiao, Xu Xie, Lin Chen, Wei Zhao, Ying Xu, Yintao Yuan, Zeng Liu, Xiaolin Yin, Aijun Wang, Zhiwen Zhang, Qing Yang, Xingsheng Su, Xuantao Kong, Beihua Song, Kun |
author_facet | Chu, Ran Zhang, Yue Qiao, Xu Xie, Lin Chen, Wei Zhao, Ying Xu, Yintao Yuan, Zeng Liu, Xiaolin Yin, Aijun Wang, Zhiwen Zhang, Qing Yang, Xingsheng Su, Xuantao Kong, Beihua Song, Kun |
author_sort | Chu, Ran |
collection | PubMed |
description | BACKGROUND: Adjuvant therapy for patients with cervical cancer (CC) with intermediate‐risk factors remains controversial. The objectives of the present study are to assess the prognoses of patients with early‐stage CC with pathological intermediate‐risk factors and to provide a reference for adjuvant therapy choice. MATERIALS AND METHODS: This retrospective study included 481 patients with stage IB–IIA CC. Cox proportional hazards regression analysis, machine learning (ML) algorithms, Kaplan‐Meier analysis, and the area under the receiver operating characteristic curve (AUC) were used to develop and validate prediction models for disease‐free survival (DFS) and overall survival (OS). RESULTS: A total of 35 (7.3%) patients experienced recurrence, and 20 (4.2%) patients died. Two prediction models were built for DFS and OS using clinical information, including age, lymphovascular space invasion, stromal invasion, tumor size, and adjuvant treatment. Patients were divided into high‐risk or low‐risk groups according to the risk score cutoff value. The Kaplan‐Meier analysis showed significant differences in DFS (p = .001) and OS (p = .011) between the two risk groups. In the traditional Sedlis criteria groups, there were no significant differences in DFS or OS (p > .05). In the ML‐based validation, the best AUCs of DFS at 2 and 5 years were 0.69/0.69, and the best AUCs of OS at 2 and 5 years were 0.88/0.63. CONCLUSION: Two prognostic assessment models were successfully established, and risk grouping stratified the prognostic risk of patients with CC with pathological intermediate‐risk factors. Evaluation of long‐term survival will be needed to corroborate these findings. IMPLICATIONS FOR PRACTICE: The Sedlis criteria are intermediate‐risk factors used to guide postoperative adjuvant treatment in patients with cervical cancer. However, for patients meeting the Sedlis criteria, the choice of adjuvant therapy remains controversial. This study developed two prognostic models based on pathological intermediate‐risk factors. According to the risk score obtained by the prediction model, patients can be further divided into groups with high or low risk of recurrence and death. The prognostic models developed in this study can be used in clinical practice to stratify prognostic risk and provide more individualized adjuvant therapy choices to patients with early‐stage cervical cancer. |
format | Online Article Text |
id | pubmed-8649058 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86490582021-12-20 Risk Stratification of Early‐Stage Cervical Cancer with Intermediate‐Risk Factors: Model Development and Validation Based on Machine Learning Algorithm Chu, Ran Zhang, Yue Qiao, Xu Xie, Lin Chen, Wei Zhao, Ying Xu, Yintao Yuan, Zeng Liu, Xiaolin Yin, Aijun Wang, Zhiwen Zhang, Qing Yang, Xingsheng Su, Xuantao Kong, Beihua Song, Kun Oncologist Gynecologic Oncology BACKGROUND: Adjuvant therapy for patients with cervical cancer (CC) with intermediate‐risk factors remains controversial. The objectives of the present study are to assess the prognoses of patients with early‐stage CC with pathological intermediate‐risk factors and to provide a reference for adjuvant therapy choice. MATERIALS AND METHODS: This retrospective study included 481 patients with stage IB–IIA CC. Cox proportional hazards regression analysis, machine learning (ML) algorithms, Kaplan‐Meier analysis, and the area under the receiver operating characteristic curve (AUC) were used to develop and validate prediction models for disease‐free survival (DFS) and overall survival (OS). RESULTS: A total of 35 (7.3%) patients experienced recurrence, and 20 (4.2%) patients died. Two prediction models were built for DFS and OS using clinical information, including age, lymphovascular space invasion, stromal invasion, tumor size, and adjuvant treatment. Patients were divided into high‐risk or low‐risk groups according to the risk score cutoff value. The Kaplan‐Meier analysis showed significant differences in DFS (p = .001) and OS (p = .011) between the two risk groups. In the traditional Sedlis criteria groups, there were no significant differences in DFS or OS (p > .05). In the ML‐based validation, the best AUCs of DFS at 2 and 5 years were 0.69/0.69, and the best AUCs of OS at 2 and 5 years were 0.88/0.63. CONCLUSION: Two prognostic assessment models were successfully established, and risk grouping stratified the prognostic risk of patients with CC with pathological intermediate‐risk factors. Evaluation of long‐term survival will be needed to corroborate these findings. IMPLICATIONS FOR PRACTICE: The Sedlis criteria are intermediate‐risk factors used to guide postoperative adjuvant treatment in patients with cervical cancer. However, for patients meeting the Sedlis criteria, the choice of adjuvant therapy remains controversial. This study developed two prognostic models based on pathological intermediate‐risk factors. According to the risk score obtained by the prediction model, patients can be further divided into groups with high or low risk of recurrence and death. The prognostic models developed in this study can be used in clinical practice to stratify prognostic risk and provide more individualized adjuvant therapy choices to patients with early‐stage cervical cancer. John Wiley & Sons, Inc. 2021-09-16 2021-12 /pmc/articles/PMC8649058/ /pubmed/34427018 http://dx.doi.org/10.1002/onco.13956 Text en © 2021 The Authors. The Oncologist published by Wiley Periodicals LLC on behalf of AlphaMed Press. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Gynecologic Oncology Chu, Ran Zhang, Yue Qiao, Xu Xie, Lin Chen, Wei Zhao, Ying Xu, Yintao Yuan, Zeng Liu, Xiaolin Yin, Aijun Wang, Zhiwen Zhang, Qing Yang, Xingsheng Su, Xuantao Kong, Beihua Song, Kun Risk Stratification of Early‐Stage Cervical Cancer with Intermediate‐Risk Factors: Model Development and Validation Based on Machine Learning Algorithm |
title | Risk Stratification of Early‐Stage Cervical Cancer with Intermediate‐Risk Factors: Model Development and Validation Based on Machine Learning Algorithm |
title_full | Risk Stratification of Early‐Stage Cervical Cancer with Intermediate‐Risk Factors: Model Development and Validation Based on Machine Learning Algorithm |
title_fullStr | Risk Stratification of Early‐Stage Cervical Cancer with Intermediate‐Risk Factors: Model Development and Validation Based on Machine Learning Algorithm |
title_full_unstemmed | Risk Stratification of Early‐Stage Cervical Cancer with Intermediate‐Risk Factors: Model Development and Validation Based on Machine Learning Algorithm |
title_short | Risk Stratification of Early‐Stage Cervical Cancer with Intermediate‐Risk Factors: Model Development and Validation Based on Machine Learning Algorithm |
title_sort | risk stratification of early‐stage cervical cancer with intermediate‐risk factors: model development and validation based on machine learning algorithm |
topic | Gynecologic Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649058/ https://www.ncbi.nlm.nih.gov/pubmed/34427018 http://dx.doi.org/10.1002/onco.13956 |
work_keys_str_mv | AT churan riskstratificationofearlystagecervicalcancerwithintermediateriskfactorsmodeldevelopmentandvalidationbasedonmachinelearningalgorithm AT zhangyue riskstratificationofearlystagecervicalcancerwithintermediateriskfactorsmodeldevelopmentandvalidationbasedonmachinelearningalgorithm AT qiaoxu riskstratificationofearlystagecervicalcancerwithintermediateriskfactorsmodeldevelopmentandvalidationbasedonmachinelearningalgorithm AT xielin riskstratificationofearlystagecervicalcancerwithintermediateriskfactorsmodeldevelopmentandvalidationbasedonmachinelearningalgorithm AT chenwei riskstratificationofearlystagecervicalcancerwithintermediateriskfactorsmodeldevelopmentandvalidationbasedonmachinelearningalgorithm AT zhaoying riskstratificationofearlystagecervicalcancerwithintermediateriskfactorsmodeldevelopmentandvalidationbasedonmachinelearningalgorithm AT xuyintao riskstratificationofearlystagecervicalcancerwithintermediateriskfactorsmodeldevelopmentandvalidationbasedonmachinelearningalgorithm AT yuanzeng riskstratificationofearlystagecervicalcancerwithintermediateriskfactorsmodeldevelopmentandvalidationbasedonmachinelearningalgorithm AT liuxiaolin riskstratificationofearlystagecervicalcancerwithintermediateriskfactorsmodeldevelopmentandvalidationbasedonmachinelearningalgorithm AT yinaijun riskstratificationofearlystagecervicalcancerwithintermediateriskfactorsmodeldevelopmentandvalidationbasedonmachinelearningalgorithm AT wangzhiwen riskstratificationofearlystagecervicalcancerwithintermediateriskfactorsmodeldevelopmentandvalidationbasedonmachinelearningalgorithm AT zhangqing riskstratificationofearlystagecervicalcancerwithintermediateriskfactorsmodeldevelopmentandvalidationbasedonmachinelearningalgorithm AT yangxingsheng riskstratificationofearlystagecervicalcancerwithintermediateriskfactorsmodeldevelopmentandvalidationbasedonmachinelearningalgorithm AT suxuantao riskstratificationofearlystagecervicalcancerwithintermediateriskfactorsmodeldevelopmentandvalidationbasedonmachinelearningalgorithm AT kongbeihua riskstratificationofearlystagecervicalcancerwithintermediateriskfactorsmodeldevelopmentandvalidationbasedonmachinelearningalgorithm AT songkun riskstratificationofearlystagecervicalcancerwithintermediateriskfactorsmodeldevelopmentandvalidationbasedonmachinelearningalgorithm |